PURPOSE: To determine prognostic factors and evaluate outcomes of transcatheter arterial embolization in severely injured patients in hemodynamically unstable condition with multicompartmental bleeding.¦MATERIALS AND METHODS: Between June 2000 and May 2008, 36 consecutive patients treated with transcatheter arterial embolization for major retroperitoneal bleeding associated with at least one additional source of bleeding were retrospectively reviewed. Mean Injury Severity Score (ISS) was 49.4 ± 15.8. Univariate and multivariate analyses were performed to identify parameters associated with failure of embolization, need for additional surgery to control bleeding, and fatal outcome at 30 d.¦RESULTS: Embolization was technically successful in ...
Abstract Background Transcatheter arterial embolization (TAE) is the first-line nonsurgical treatmen...
PURPOSE: To evaluate the efficacy and safety of transcatheter arterial embolization of the pelvic ar...
IF 2.443International audienceTo assess the efficacy and the safety of Glubran®2 n-butyl cyanoacryla...
PURPOSE: To determine prognostic factors and evaluate outcomes of transcatheter arterial embolizatio...
Purpose: To evaluate the prognostic factors that influence the survival of patients with traumatic i...
International audienceBACKGROUND AND AIMS:: Severe bleeding from gastrointestinal ulcers is a life-t...
Background: To evaluate the clinical efficacy and identify the predictors of outcome of intercostal ...
Background: Transcatheter arterial embolization can be used for patients with recurrent bleeding fro...
BACKGROUND: Endovascular intervention is now the primary line of therapy for arterial injury brought...
Objectives This article assesses potential factors associated with successful embolization and/or mo...
PURPOSE: To evaluate the role of endovascular treatment for controlling haemorrhage in haemodynamic...
PURPOSE: The aim of study was to evaluate the results of our experience with transarterial embolizat...
International audiencePurposeTo assess the efficacy and safety of n-butyl cyanoacrylate methacryloxy...
Background: To evaluate the clinical efficacy and identify the predictors of outcome of intercostal ...
OBJECTIVE: To investigate the safety and efficacy of transcatheter arterial embolisation (TAE) in th...
Abstract Background Transcatheter arterial embolization (TAE) is the first-line nonsurgical treatmen...
PURPOSE: To evaluate the efficacy and safety of transcatheter arterial embolization of the pelvic ar...
IF 2.443International audienceTo assess the efficacy and the safety of Glubran®2 n-butyl cyanoacryla...
PURPOSE: To determine prognostic factors and evaluate outcomes of transcatheter arterial embolizatio...
Purpose: To evaluate the prognostic factors that influence the survival of patients with traumatic i...
International audienceBACKGROUND AND AIMS:: Severe bleeding from gastrointestinal ulcers is a life-t...
Background: To evaluate the clinical efficacy and identify the predictors of outcome of intercostal ...
Background: Transcatheter arterial embolization can be used for patients with recurrent bleeding fro...
BACKGROUND: Endovascular intervention is now the primary line of therapy for arterial injury brought...
Objectives This article assesses potential factors associated with successful embolization and/or mo...
PURPOSE: To evaluate the role of endovascular treatment for controlling haemorrhage in haemodynamic...
PURPOSE: The aim of study was to evaluate the results of our experience with transarterial embolizat...
International audiencePurposeTo assess the efficacy and safety of n-butyl cyanoacrylate methacryloxy...
Background: To evaluate the clinical efficacy and identify the predictors of outcome of intercostal ...
OBJECTIVE: To investigate the safety and efficacy of transcatheter arterial embolisation (TAE) in th...
Abstract Background Transcatheter arterial embolization (TAE) is the first-line nonsurgical treatmen...
PURPOSE: To evaluate the efficacy and safety of transcatheter arterial embolization of the pelvic ar...
IF 2.443International audienceTo assess the efficacy and the safety of Glubran®2 n-butyl cyanoacryla...